cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Deciphera Pharmaceuticals Inc
5 own
8 watching
Current Price
$25.51
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,050.91M
52-Week High
52-Week High
25.55000
52-Week Low
52-Week Low
9.90000
Average Volume
Average Volume
1.05M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,050.91M
icon52-Week High25.55000
icon52-Week Low9.90000
iconAverage Volume1.05M
iconDividend Yield--
iconP/E Ratio--
What does the Deciphera Pharmaceuticals Inc do?
Deciphera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response of various cancer therapies. The company's lead drug candidate is DCC-2618, which is in Phase III trial for the treatment of gastrointestinal stromal tumors; and that is in Phase I trial for treating advanced systemic mastocytosis, gliomas, melanoma, NSCLC/germ cell/penile, and soft tissue sarcomas. It is also developing immunokinase inhibitors comprising DCC-3014 that is in Phase I trial for treatment of solid tumors and hematologic malignancies; and Rebastinib, which is in Phase 1b/II trial to treat solid tumors, as well as to investigate in combination with chemotherapy for the treatment of multiple solid tumors. The company was founded in 2003 and is headquartered in Waltham, Massachusetts.
Read More
How much money does Deciphera Pharmaceuticals Inc make?
News & Events about Deciphera Pharmaceuticals Inc.
Benzinga
1 year ago
read more...
Business Wire
1 year ago
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in fireside chats at the...
Market News Video
1 year ago
In trading on Thursday, shares of Deciphera Pharmaceuticals Inc (DCPH) crossed below their 200 day moving average of 15.37, changing hands as low as 14.88 per share. Deciphera Pharmaceuticals Inc shares are currently trading off about 2.3% on the day...
Ticker Report
1 year ago
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH Get Rating) major shareholder Brightstar Associates Llc bought 1,666,666 shares of Deciphera Pharmaceuticals stock in a transaction that occurred on Tuesday, January 24th. The shares were acquired at an average cost of $18.00 per share, for a ...
Frequently Asked Questions
Frequently Asked Questions
What is Deciphera Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Deciphera Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Deciphera Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Deciphera Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Deciphera Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Deciphera Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Deciphera Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Deciphera Pharmaceuticals Inc?
plus_minus_icon
What percentage is Deciphera Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Deciphera Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$25.51
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00